CONNECT WITH US:
Jun 12, 2019 15:00 JST
Singapore eDevelopment Ltd
Global BioLife's 3F Mosquito Repellent Formula performs well in Independent Testing
SINGAPORE, Jun 12, 2019 - (ACN Newswire) - SGX-listed Singapore eDevelopment Ltd (SeD) wishes to announce that U.S. biomedical subsidiary Global BioLife Inc. has independently tested its new 3F Mosquito Formula which performs well against mosquitoes for six (6) to eight (8) hours.
In 2017, SeD announced a collaboration between Global BioLife and U.S. based Chemia Corporation to develop a suite of fragrances referred to as 3F (Functional Fragrance Formulation). Previous testing was promising for the 3F Mosquito Fragrance, which is made of specialised oils sourced from botanicals that mosquitoes avoid in varying concentrations of 0.25% to 5%.
Global BioLife contracted U.S. based Snell Scientifics, LLC in Meansville, Georgia to conduct a study on the new mosquito repellent formula and the results of the study showed that it repelled between 82% to 95% of mosquitos for six (6) hours after application.
"Utilising fragrances to repel mosquitos with this level of efficacy is a game changer for the consumer products industry," said Mr. Thomas A. Meyer, Chemia's Vice-President of Innovation and Sustainability.
Globally, an estimated 3.4 billion people in 92 countries are at risk of being infected with Zika, Dengue, West Nile Virus, Malaria and other mosquito transmitted diseases. Mosquito repellent products are key in the fight against mosquito transmitted diseases, while a product favoured by consumers is easy to apply, is considered safe, and does not have unpleasant attributes such as a strong chemical odour.
The market for safe mosquito repellents is expanding, and consumers have expressed a demand for effective mosquito repellent products with appealing scents. The most recently tested product has a fragrance that is modeled on the fresh scent of the Ghost Orchid, a rare flower known for its distinctive and pleasant aroma found in the Everglades of Florida.
"3F Mosquito works differently from traditional insect repellents. It's effective even at very low concentrations due to its multi-aspect receptor inhibition," said Mr. Daryl Thompson, Global BioLife's Director of Scientific Initiatives.
"Global BioLife is extremely proud of these test results," said SeD's Executive Chairman Mr. Chan Heng Fai. "3F is an innovative product that works in an entirely different manner from any other product on the market today. 3F is a true success for people everywhere and will help reduce the number of mosquito transmitted diseases on a global scale."
Global BioLife is currently in discussions with interested companies for potential licensing and global deployment of this new mosquito repellent formula.
About Singapore eDevelopment Limited
Incorporated on 9 September 2009 and listed on the Singapore Exchange in July 2010, Singapore eDevelopment Limited is involved in (i) property development and investments primarily in the United States and Western Australia; (ii) information technology-related businesses; (iii) development, research, testing, manufacturing, licensing and distribution of biomedical products; and (iv) investment activities. For more information, please visit: www.SeD.com.sg or email
About Global BioLife Inc.
Global BioLife Inc. ("GBLI") is a 70%-held direct subsidiary of Global BioMedical Inc., which is a wholly-owned direct subsidiary of Singapore BioMedical Pte. Ltd., which in turn is a wholly-owned direct subsidiary of Singapore eDevelopment Limited, a company listed on the Singapore Exchange. The remaining shareholding of Global BioLife Inc. is held by Global Research and Discovery Group Scientific LLC ("GRDGS") at 20% and Australian Exchange-listed Holista CollTech Limited ("Holista") at 10%. For more information, please visit:
About GRDG Sciences, LLC.
GRDG Sciences, LLC is an advanced research team formed in Florida by natural products discovery drug research scientist, Daryl Thompson. For more information, please visit:
Source: Singapore eDevelopment Ltd
Sectors: HealthCare, Cosmetics/Spec.Chem
Copyright ©2020 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Rakuten Mobile and NEC Agree to Jointly Develop Containerized Standalone 5G Core Network
Jun 03, 2020 10:34 JST
The Toyota Mobility Foundation and Partners Establish Digital Platform to Help Support People and Industry in Rural Germany
Jun 03, 2020 09:05 JST
Mitsubishi Corporation and NTT complete investment in HERE Technologies
Jun 02, 2020 14:54 JST
Toyota Announces its Line-up for the New GR Yaris in Japan
Jun 02, 2020 13:35 JST
Eisai Launches New Insomnia Drug Dayvigo (Lemborexant) CIV in the United States as a Treatment Option for Adults With Insomnia
Jun 02, 2020 11:05 JST
MHI RJ Aviation Group Launches as Mitsubishi Heavy Industries Ltd. Closes Acquisition of CRJ Series Program From Bombardier Inc.
Jun 02, 2020 10:23 JST
LEXUS previews the New IS
Jun 02, 2020 09:12 JST
DENSO and Certhon Establish DENSO AgriTech Solutions
Jun 01, 2020 12:48 JST
Fujitsu Signs Partnership Agreement with Scaled Agile, Inc., Driving Large-Scale Agile for Digital Transformation
Jun 01, 2020 12:01 JST
AbbVie and Eisai Announce an Approval for Partial Changes in the Marketing Approval of HUMIRA, a Fully Human Anti-TNFalpha Monoclonal Antibody
May 29, 2020 15:54 JST
Sharp Releases Notice of Corporate Spin-Off of the Display Device Business Division
May 29, 2020 15:47 JST
DENSO Announces Changes in the Areas of Responsibility of Senior Executive Officers and Executive Officers
May 29, 2020 12:05 JST
Eisai: Results from LENVIMA (lenvatinib) plus KEYTRUDA (pembrolizumab) Trials
May 29, 2020 11:31 JST
Hitachi Announces Change in the Effective Date for Company Split and Closing Date of Share Transfer
May 28, 2020 19:18 JST
Mitsubishi Motors Announces Production, Sales and Export Figures for April 2020
May 28, 2020 19:09 JST
Honda Sets Monthly Records for Automobile Production in China
May 28, 2020 18:52 JST
Mazda Production and Sales Results for April 2020
May 28, 2020 16:46 JST
Mazda Joins IP Open Access Declaration Against Covid-19
May 28, 2020 16:28 JST
Toyota Releases Sales, Production, and Export Results for April 2020
May 28, 2020 13:56 JST
Fujitsu Accelerates Digital Transformation with Flexible, Scale-out Software-Defined Storage ETERNUS Data Services Platform
May 28, 2020 11:26 JST
More Latest Release >>
Impact Biomedical and GRDG Sciences Announce Medical Technology Package Valued at USD 1.39 Billion (SGD 1.97 Billion) by Independent Experts
June 01 2020 13:00 JST
Impact Biomedical's Majority Owned Next Generation Medical Technologies Valued at USD 592 Million (SGD 841 Million) by Independent Experts
April 24 2020 10:00 JST
Impact BioMedical's Linebacker and Equivir inhibit SARS-CoV-2, virus responsible for the COVID-19 outbreak
March 18 2020 11:00 JST
Global BioLife to Present 3F Antimicrobial Fragrance at 2020 ASM Biothreats
November 15 2019 02:00 JST
Global BioLife to present Functional Fragrance Formula at the American Society for Microbiology's Biothreats Conference as a New Method to Prevent and Treat Tuberculosis
October 29 2019 09:00 JST
Global BioLife unveils naturally modified Laetose at Harvard Global Catalyst Health Summit
July 24 2019 15:00 JST
Global BioLife's 3F Antimicrobial Fragrance shows Efficacy against Tuberculosis
January 28 2019 12:00 JST
Singapore eDevelopment's Global BioLife to present Parkinson's Research at Neuroscience 2018
November 07 2018 19:00 JST
Singapore eDevelopment Limited Announces Corporate and Business Update
June 18 2018 19:00 JST
Singapore eDevelopment's Global BioLife develops Low Glycemic Modified Sugar
May 31 2018 18:00 JST
More Press release >>